Respiratory Care |

Management and Follow Up of Noninvasive Ventilation in a Third Level Hospital: A Descriptive Study FREE TO VIEW

Rosa Mirambeaux Villalona, MD; Deisy Barrios Barreto, MD; Salvador Diaz Lobato, PhD; Paola Arrieta Narvaez, MD; Carolina Gotera, MD; Patricia Lazo Meneses, MD; Carolina Jurkojc Mohremberger, MD; Sagrario Mayoralas Alises, PhD; Esteban Perez Rodriguez, PhD
Author and Funding Information

Ramon y Cajal Hospital, Madrid, Spain

Chest. 2014;145(3_MeetingAbstracts):542A. doi:10.1378/chest.1823993
Text Size: A A A
Published online


SESSION TITLE: Respiratory Support Posters

SESSION TYPE: Poster Presentations

PRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PM

PURPOSE: Emphasize the importance of proper monitoring of the non-invasive ventilation (NIV) to asssure the compliance of the therapeutic objectives.

METHODS: A descriptive, retrospective and longitudinal study during 2012-2013 was completed. Three hundred patients with NIV criteria were evaluated by assessment of patient comfort, respiratory rate, cardiac rate, oxygen saturation, chest wall motion, accessory muscle recruitment, coordination of respiratory effort with the ventilator, conscious level, and arterial blood gas tensions (pH, pCO2) in the first hour, second hour if needed, 6 hours and 24 hours.

RESULTS: Three hundred patients were analyzed, 182 (60.6 %) men and 118 (39.3 %) women, in which 193 (64.3 %) presented respiratory acidosis, 56 (18 %) presented acute cardiogenic pulmonary edema, and 53 (17.6 %) were postoperative patients, bronchoscopy, and weaning complicated in intubated patients. The principal diagnoses were COPD 136 (45.3 %), chronic cardiac failure 54 (18 %), obstructive sleep apnea- hypopnea syndrome (OSAHS) 38 (12.67 %), restrictive pulmonary disease 22 (7.3 %), neuromuscular diseases 16 (5.4 %), and others 34 (11.3 %). Out of the 300 cases, 219 (73 %) had improvement in the arterial blood gas tensions (pH> 7.35) in the first 24hrs, 108 (36 %) presented therapeutic failure, in which 3 (1%) were considered for invasive ventilation, 42 (14 %) were due to intolerance to the NIV, and 36 (12%) %) died.

CONCLUSIONS: It is vitally important to recognize the need for suitable management and a close follow-up of the patient with indication for NIV. We have to consider a complete clinical evaluation combined with a continual assessment of the ventilatory parameters, arterial blood gas tension, and the pulmonary mechanics for at least 24 hours after initiating NIV, to verify the successful outcome from NIV, and to detect complications and therapeutic failure that could determine the discontinuation of NIV or to consider invasive ventilation.

CLINICAL IMPLICATIONS: Contribute to the proper management of the NIV.

DISCLOSURE: The following authors have nothing to disclose: Rosa Mirambeaux Villalona, Deisy Barrios Barreto, Salvador Diaz Lobato, Paola Arrieta Narvaez, Carolina Gotera, Patricia Lazo Meneses, Carolina Jurkojc Mohremberger, Sagrario Mayoralas Alises, Esteban Perez Rodriguez

No Product/Research Disclosure Information




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543